Vericel Corporation
Vericel Corporation
VCEL
Valuace
23
Růst
73
Zdraví
75
Cena
$ 38.91
Dnes
--1.17 (-3.03%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.0B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
4%
ROA
3%
PE
99
PS
6
Cena 1R
29-63
⌀ Cena
38.02
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

Vericel Corporation, biofarmaceutická společnost působící v komerčním měřítku, se zabývá výzkumem, vývojem, výrobou a distribucí buněčných terapií pro sportovní medicínu a trhy s těžkou popáleninovou péčí ve Spojených státech. Společnost prodává přípravky pro autologní buněčnou terapii zahrnující MACI, autologní celulární lešení pro opravu symptomatických a jednorázových nebo vícenásobných vad chrupavky kolene v plné tloušťce; a Epicel, trvalé náhradní kožní humanitární zařízení pro léčbu dospělých a pediatrických pacientů s popáleninami v hlubokých kůžích nebo v plné tloušťce. Jeho předschváleným produktem je NexoBrid, biologický sirotčí produkt ve stadiu registrace pro odstraňování jícnu u dospělých s hlubokými tepelnými popáleninami o částečné tloušťce a/nebo plné tloušťce. Společnost byla dříve známá jako Aastrom Biosciences, Inc. Vericel Corporation byla založena v roce 1989 a sídlí v Cambridge v Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
357
Založení
1997-02-04
Adresa
64 Sidney Street
CEO
Dominick C. Colangelo
Web

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues276.3276.3237.2197.5164.4156.2124.2117.990.963.954.451.228.80.00.00.00.1
Cost of Revenues70.770.765.161.954.650.240.037.632.230.428.326.517.30.00.00.00.0
Gross Profit205.6205.6172.1135.6109.8106.084.280.358.733.626.124.711.50.00.00.00.1
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues92.967.563.252.675.457.952.751.365.045.6
Cost of Revenues19.817.916.616.316.916.316.115.916.515.0
Gross Profit73.149.646.636.358.541.736.635.448.530.6
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.021.019.916.313.030.413.612.915.318.921.315.126.021.312.7
Selling General & Admin Expenses0.00.00.0121.0106.997.668.861.149.035.627.422.513.85.97.87.75.2
Depreciation & Amortization11.711.45.54.61.40.32.41.61.41.61.91.60.80.50.60.60.6
Total Operating Expenses194.6194.6167.6142.0126.8113.981.991.562.648.642.741.435.021.033.829.117.9
Operating Income11.011.04.5-6.5-17.1-7.90.7-11.3-3.9-15.0-19.2-16.7-23.5-21.0-33.8-29.0-17.8
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.04.95.7
Selling General & Admin Expenses0.00.00.00.00.00.00.00.030.930.0
Depreciation & Amortization3.32.92.82.71.51.31.31.41.11.2
Total Operating Expenses50.746.148.649.140.044.142.640.835.835.7
Operating Income22.43.5-2.0-12.818.5-2.5-6.0-5.512.7-5.1
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income7.07.06.44.61.30.20.71.60.90.00.00.00.00.00.10.10.1
Interest Expense0.61.60.60.60.40.00.00.01.71.10.30.00.00.00.00.00.0
Other Expense6.36.36.04.11.10.32.41.6-3.4-1.2-2.70.33.65.34.29.30.1
IBT17.417.410.5-2.4-16.0-7.63.0-9.7-8.1-17.3-19.6-16.3-19.9-15.6-29.5-19.7-17.7
Income Tax Expense0.90.90.10.80.7-0.10.2-1.83.41.12.6-0.3-3.6-5.3-4.2-18.7-0.1
Net Income16.516.510.4-3.2-16.7-7.52.9-7.9-8.1-17.3-19.6-16.3-19.9-15.6-29.5-19.7-17.7
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income1.91.81.71.71.61.61.51.81.41.3
Interest Expense0.20.20.20.20.20.20.20.20.20.2
Other Expense1.71.61.51.51.51.61.31.61.41.1
IBT24.15.1-0.6-11.220.0-0.9-4.7-3.914.1-3.9
Income Tax Expense0.90.00.00.00.10.00.00.01.1-0.3
Net Income23.25.1-0.6-11.219.8-0.9-4.7-3.913.0-3.7
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-0.07$-0.35$-0.16$0.06$-0.18$-0.20$-0.52$-0.85$-0.69$-1.71$-5.18$-14.31$-10.19$-14.34
EPS Diluted$0.00$0.00$0.00$-0.07$-0.35$-0.16$0.06$-0.18$-0.20$-0.52$-0.85$-0.69$-1.71$-5.18$-14.31$-10.19$-14.34
Shares Outstanding50.650.648.847.647.146.545.244.240.233.423.123.811.63.02.11.91.2
Diluted Shares Outstanding52.152.151.747.647.146.547.344.240.233.423.123.811.63.02.11.91.2
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.27$-0.08
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.26$-0.08
Shares Outstanding50.650.550.449.949.549.148.748.147.747.6
Diluted Shares Outstanding52.151.950.449.952.249.148.748.150.547.6
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents75.974.569.151.168.333.626.918.326.923.014.630.38.113.65.531.2
Short Term Investments52.241.740.568.535.142.242.864.60.00.00.00.00.00.00.05.0
Total Cash & ST Investments128.1116.2109.6119.5103.475.869.782.926.923.014.630.38.113.65.531.2
Accounts Receivable48.061.458.446.537.434.532.223.518.317.110.98.20.00.00.00.0
Inventory14.917.413.116.013.49.46.83.63.83.51.41.90.00.00.00.0
Other Current Assets6.417.824.64.84.23.93.02.81.61.20.51.00.40.30.60.4
Total Current Assets197.4212.8205.6186.9158.5123.6111.7112.850.544.727.341.58.514.06.231.7
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents100.480.573.574.553.750.370.786.960.543.0
Short Term Investments35.036.339.441.748.152.247.740.544.954.8
Total Cash & ST Investments135.4116.9112.9116.2101.7102.5118.5127.3105.397.8
Accounts Receivable60.464.352.961.448.548.049.958.439.738.3
Inventory18.216.817.117.415.814.913.613.112.613.9
Other Current Assets8.06.614.717.824.632.07.824.628.532.8
Total Current Assets222.0204.6197.6212.8190.5197.4189.7205.6186.2182.9
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment146.1173.3115.157.459.057.732.25.94.13.94.02.90.71.21.61.1
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets6.66.36.97.50.00.00.00.00.00.02.93.20.00.00.00.0
Long-Term Investments26.139.925.320.025.724.19.20.00.00.00.00.00.00.00.00.0
Other Long-Term Assets0.70.60.81.30.50.20.10.00.00.00.00.00.00.00.00.0
Total Long-Term Assets179.5219.9148.086.185.282.041.65.94.13.97.06.10.71.21.61.1
Total Assets376.8432.7353.7273.0243.7205.6153.2118.754.648.634.347.69.215.27.732.8
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment175.5177.2177.0173.3160.0146.1130.1115.1103.598.5
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets5.85.96.16.36.46.66.76.97.07.2
Long-Term Investments49.747.443.339.932.926.129.425.320.221.0
Other Long-Term Assets0.40.40.50.60.60.70.70.81.11.2
Total Long-Term Assets231.3231.0226.9219.9199.9179.5166.9148.0131.9127.8
Total Assets453.3435.6424.6432.7390.4376.8356.7353.7318.1310.7
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable25.223.822.316.99.06.86.37.15.66.57.65.82.42.82.20.0
Short-Term Debt5.89.312.44.33.04.45.50.00.40.80.00.00.00.00.00.2
Other Current Liabilities12.917.27.916.20.00.00.07.71.21.04.56.02.02.016.629.7
Current Liabilities43.950.345.737.526.122.519.814.813.112.912.111.85.35.720.729.9
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable15.312.916.823.820.925.219.422.315.114.4
Short-Term Debt27.713.811.29.36.15.86.012.414.57.2
Other Current Liabilities2.614.511.517.214.312.911.011.06.414.0
Current Liabilities45.641.139.450.341.343.936.545.735.935.6
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt89.889.681.943.347.148.822.20.016.99.40.10.00.00.00.00.0
Capital Leases90.098.988.047.650.153.227.70.00.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.0-27.9-11.40.00.00.00.00.00.0
Total Liabilities133.9140.8127.780.773.271.342.116.532.023.912.211.95.35.720.729.9
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt85.886.087.889.691.389.886.381.977.876.1
Capital Leases98.099.899.098.997.595.686.382.085.183.4
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities131.4128.8129.1140.8132.9133.9122.8127.7113.7111.8
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock655.0684.8629.2593.2553.9510.1489.7471.2383.0329.7307.8305.0253.3243.2228.9231.3
Retained Earnings-411.7-392.8-403.2-400.0-383.3-375.8-378.7-369.0-360.9-343.6-324.0-307.7-287.8-275.3-241.8-222.2
Comprehensive Income-0.30.0-0.1-1.0-0.20.00.00.0-6.6-7.1-5.6-0.1-4.1-3.60.00.0
Total Common Equity243.0292.0226.0192.3170.5134.3111.1102.222.524.722.135.63.99.5-13.02.9
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock721.1711.2699.4684.8669.7655.0641.2629.2621.0612.1
Retained Earnings-399.5-404.6-404.1-392.8-412.6-411.7-407.0-403.2-416.2-412.5
Comprehensive Income0.30.20.10.00.4-0.3-0.2-0.1-0.5-0.6
Total Common Equity321.9306.8295.5292.0257.5243.0233.9226.0204.4198.9
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt95.898.988.147.650.153.227.70.017.210.10.10.10.00.00.10.3
Book Value243.0292.0226.0192.3170.5134.3111.1102.222.524.722.135.63.99.5-13.02.9
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value321.9306.8295.5292.0257.5243.0233.9226.0204.4198.9
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income0.816.510.4-3.2-16.7-7.52.9-9.7-8.1-17.3-19.6-16.3-19.9-15.6-29.5-19.7-17.7
Depreciation & Amortization5.011.45.54.64.03.02.41.71.41.61.91.60.80.50.60.60.6
Stock-Based Compensation34.238.836.532.337.234.313.813.27.22.72.52.70.80.93.63.70.7
Change Working Capital-3.6-21.4-0.5-4.0-11.2-6.2-6.4-14.7-4.0-1.6-9.2-1.3-2.5-0.4-0.10.11.3
Change In Accounts Receivable-9.7-23.3-3.0-11.8-9.1-2.9-2.3-8.7-5.2-1.2-6.2-2.7-8.10.00.00.00.0
Change In Accounts Payable1.93.0-0.33.01.41.50.0-1.00.9-1.4-1.11.72.80.30.30.90.0
Change In Inventories-1.0-1.2-4.32.9-2.6-4.0-2.5-3.30.2-0.7-2.2-0.10.10.00.30.00.0
Other Non-cash Items49.06.66.3-0.43.74.44.42.83.10.01.8-0.1-4.6-5.3-4.2-29.00.0
Cash from Operations43.00.00.035.317.729.017.6-7.2-0.4-13.2-19.9-13.3-25.4-19.9-29.5-24.5-15.1
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income23.25.1-0.6-11.219.8-0.9-4.7-3.913.0-3.7
Depreciation & Amortization3.32.92.72.71.50.81.31.41.11.2
Stock-Based Compensation8.48.710.111.57.99.29.59.86.97.9
Change Working Capital-22.34.1-5.52.3-8.4-1.010.9-1.9-12.80.2
Change In Accounts Receivable-24.23.9-11.48.5-12.9-0.51.98.4-18.6-1.4
Change In Accounts Payable0.72.80.0-0.61.4-1.44.7-4.92.7-0.6
Change In Inventories-0.4-1.30.30.3-1.6-0.9-1.3-0.5-0.51.3
Other Non-cash Items2.31.31.51.31.52.11.51.727.41.9
Cash from Operations0.00.00.00.00.00.00.00.010.17.2
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-45.20.00.00.0-7.6-7.9-2.6-2.6-2.7-1.5-1.4-2.4-0.80.0-0.3-1.0-0.1
Acquisitions-13.10.00.00.07.67.92.62.62.70.00.00.0-1.50.00.00.00.0
Investments-62.4-72.4-68.2-55.2-69.6-60.0-63.1-72.3-66.50.00.00.00.00.00.0-5.0-5.0
Sales of Investment60.955.653.279.640.964.448.585.62.20.00.00.00.00.00.00.00.0
Other Investing Activities-20.60.00.0-27.5-7.6-7.9-2.6-2.6-2.70.00.00.00.10.00.05.00.0
Cash from Investing-46.70.00.0-3.1-36.2-3.5-17.210.6-67.0-1.5-1.4-2.4-2.20.0-0.3-1.0-5.1
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-14.2-2.614.2-14.2-13.830.8-16.8-14.0-7.8-6.6
Acquisitions0.00.00.00.00.00.00.00.0-19.76.6
Investments-28.9-14.5-15.5-13.4-15.6-16.9-13.1-22.6-19.0-7.7
Sales of Investment14.713.814.712.514.715.112.211.118.718.9
Other Investing Activities0.00.00.00.00.00.00.00.00.0-6.6
Cash from Investing0.00.00.00.00.00.00.00.0-8.14.6
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid0.00.00.00.00.00.00.00.0-17.5-8.0-2.40.00.00.00.0-0.2-0.5
Debt Issued12.498.910.740.6-2.5-3.125.527.70.315.112.50.00.10.00.00.10.7
Issuance of Common Stock14.00.00.06.03.711.20.00.074.48.219.50.049.914.40.30.017.5
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities-5.20.00.0-2.4-2.6-2.06.45.32.018.412.70.00.00.037.60.00.3
Cash from Financing8.70.00.03.61.09.26.45.358.918.629.70.049.914.437.9-0.217.3
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued98.0-1.80.80.11.41.93.34.23.11.7
Issuance of Common Stock0.00.00.00.00.00.00.00.01.41.1
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-0.1-0.1
Cash from Financing0.00.00.00.00.00.00.00.01.31.0
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash5.015.0-1.835.8-17.534.76.98.7-8.63.98.4-15.822.3-5.68.1-25.7-2.9
Closing Cash Balance75.9100.185.086.951.168.533.827.018.326.923.014.630.38.113.65.514.1
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-0.319.90.8-5.314.7-5.55.1-16.13.312.7
Closing Cash Balance100.1100.480.579.785.070.475.970.786.983.6
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-2.224.7-5.87.810.121.114.9-9.8-3.1-14.7-21.3-15.8-26.2-20.0-29.8-25.5-15.2
Real Free Cash Flow-36.4-14.0-42.3-24.5-27.1-13.21.1-23.0-10.3-17.4-23.8-18.5-27.1-20.9-33.4-29.3-15.9
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow0.819.522.4-7.68.541.01.8-6.82.30.6
Real Free Cash Flow-7.610.812.3-19.10.531.7-7.7-16.6-4.7-7.3
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E99-5514.5-1.4
P/S5.97.19.4
P/B5.17.85.2
P/FCF-442.2133.6-1.5
Market cap$2.0$1.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets21.6 %13.1 %0 %
Debt to Income593.3 %-13055.2 %0 %
Debt to Free cash flow-2649.5 %-37747.9 %0 %
Interest expense percentage5.7 %-3.6 %44.7 %
Current ratio4.9 4.2 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE5.1 %-57.4 %0 %
ROA3.6 %-51 %0 %
CapEx to Revenue6.3 %226.3 %0 %
RaD to Revenue0 %8753.2 %0 %
ROEM773,834.7 251275.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin73.8 %74.5 %68.7 %
Operating margin2.7 %-11815 %35.5 %
Net margin5.1 %-9921.7 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding51.9 mil 29.9 mil
Employee count0.4 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader